Israel Englander Bausch & Lomb Corp Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.6 - $17.06 $90,956 - $114,097	-6,688 Reduced 34.17%	12,886 $187,000
Q1 2024 May 15, 2024	SELL	$13.68 - $17.6 $251,424 - $323,470	-18,379 Reduced 48.43%	19,574 $338,000
Q4 2023 Feb 14, 2024	SELL	$14.87 - $17.56 $127,287 - $150,313	-8,560 Reduced 18.4%	37,953 $647,000
Q2 2023 Aug 14, 2023	SELL	$16.03 - $20.07 $334,465 - $418,760	-20,865 Reduced 30.97%	46,513 $933,000
Q1 2023 May 15, 2023	SELL	$15.67 - $18.91 $365,079 - $440,565	-23,298 Reduced 25.69%	67,378 $1.17 Million
Q4 2022 Feb 14, 2023	BUY	$13.5 - $17.14 $1.22 Million - $1.55 Million	90,676 New	90,676 $1.41 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.